Bivalent CAR-T Cells Via CSF Injection Show Activity in Recurrent Glioblastoma

By News Health
2 days Ago

(MedPage Today) — CHICAGO — Intracerebroventricular (ICV) delivery of bivalent CAR T-cells targeting EGFR and IL13Rα2 was feasible and appeared safe in patients with recurrent glioblastoma (GBM) in a phase I study that also signaled an…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115865

Author :

Publish date : 2025-06-02 20:43:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

CDC Expert Resigns From COVID Vax Role; FDA to Probe Abortion Drug; Measles Update

Intestinal Ultrasound Wins in Early Crohn’s Prognosis

Should You Consider CGMs for Patients With Early Diabetes?

Can a Majority of Sudden Cardiac Arrests Be Prevented?

Adhesive made from wood works in a standard glue gun

Don’t Forget These Infectious Disease Screenings